Effect of Kangfuxin Solution on Chemo/Radiotherapy-Induced Mucositis in Nasopharyngeal Carcinoma Patients: A Multicenter, Prospective Randomized Phase III Clinical Study
Table 1
Demographics and baseline characteristics of the efficacy population (%).
Characteristics
Test group
Control group
Gender
F
70 (65.4)
83 (76.9)
0.064
M
37 (34.6)
25 (23.2)
Age
46.3 ± 11.0
48.0 ± 10.0
0.241
Height (cm)
162.4 ± 7.7
163.4 ± 6.9
0.283
Weight (kg)
59.3 ± 10.9
61.7 ± 10.5
0.100
Allergic history
No
102 (95.3)
105 (97.2)
0.499
Yes
5 (4.7)
3 (2.8)
Clinical stage
I/II
12 (11.2)
18 (16.7)
0.649
III/IV
95 (88.8)
90 (83.3)
KPS
100
3 (2.8)
3 (2.8)
0.629
90
96 (89.7)
92 (85.2)
80
8 (7.5)
12 (11.1)
70
0 (0.00)
1 (0.92)
TX
XRT
3 (2.8)
8 (7.4)
0.126
CRT
104 (97.2)
100 (92.6)
TX time (day)
48.3 ± 37.3
43.6 ± 41.5
0.388
Medical history
No
87 (81.3)
85 (78.7)
0.633
Yes
20 (18.7)
23 (21.3)
Existing history of disease
No
93 (86.9)
95 (88.0)
0.817
Yes
14 (13.1)
13 (12.0)
Chi-squared test. Fisher exact probability method. -test. M, male; F, female; TX, treatment; XRT, radiotherapy; CRT, chemoradiotherapy.
